Showing 1201-1210 of 2050 results for "".
- Survey: More than Half of Americans Seek Skin Care and Other Products Aligned with Sustainable Lifestyleshttps://modernaesthetics.com/news/survey-more-than-half-of-americans-seek-skin-care-and-other-products-aligned-with-sustainable-lifestyles/2473563/A recent consumer sentiment survey showed that over half of Americans are inclined to try new products (including those for skin care) marketed as aligned with healthier and more sustainable lifestyles. The survey, conducted by NCSolutions, showed a significant emphasis on health and en
- Allergan Aesthetics Launches Program to Elevate the Conversation Around Ethics in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-launches-program-to-elevate-the-conversation-around-ethics-in-aesthetics/2473556/Allergan Aesthetics announced the launch of 'Moving the Needle on Ethics,' a collaboration with medical aesthetics experts from around the globe aimed at elevating discussions on ethics in aesthetics. The collection of interviews is designed to highlight the
- Letybo (letibotulinumtoxinA-wlbg) Receives FDA Approvalhttps://modernaesthetics.com/news/fda-grants-approval-for-letybo-letibotulinumtoxina-wlbg/2473551/Hugel America, Inc., announced the achievement of a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for its neurotoxin, Letybo. "We are thrilled with the FDA's approval of Letybo. This is a huge achievement for Hugel as we
- Cutera Launches AviClear for the Treatment of Acne in UK, Europe and Australiahttps://modernaesthetics.com/news/cutera-launches-aviclear-for-the-treatment-of-acne-in-uk-europe-and-australia/2473548/Cutera announced the international limited commercial release of AviClear, which the company describes as the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear is now commercially available, on a limited basis, in the UK, Europe, a
- Genese Labs Introduces the RG60 Body Fillerhttps://modernaesthetics.com/news/genese-labs-introduces-the-rg60-body-filler/2473539/Genese Labs France is rolling out the RG60 Body Filler, an injectable composed of a 24mg/ml cross-linked hyaluronic acid concentration. RG60 can be used in the face and body including the buttocks. Free from lidocaine, RG60 ensures a safer experience
- AestheticWires’s Toxin Pipeline Watch: RelabotulinumtoxinA Smoothes Crow’s Feet and Frown Lines Quickly and Results Last in Phase IIIb Studieshttps://modernaesthetics.com/news/aestheticwiress-toxin-pipeline-watch-relabotulinumtoxina-smoothes-crows-feet-and-frown-lines-quickly-and-results-last-in-phase-iiib-studies/2473537/RelabotulinumtoxinA produces rapid and long-lasting effects on crow’s feet and frown kines, according to topline results from two phase IIIb studies. Galderma’s relabotulinumtoxinA is a novel liquid formulation of botulinum toxin A currently being investigated globally.
- Exosome X Mitochondrial Technology: Elevai Labs Enters Into Licensing Agreement With Yuva Bioscienceshttps://modernaesthetics.com/news/exosome-x-mitochondrial-technologies-elevai-labs-enters-into-licensing-agreement-with-yuva-biosciences/2473536/Elevai Labs, Inc. signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx (Precision Regenerative Exosome Technology) in topical skincare. The potential collab could com
- Exosome Update: ELEVAI Labs Announces Pricing of $6,000,000 IPOhttps://modernaesthetics.com/news/exosome-update-elevai-labs-announces-pricing-of-6000000-ipo/2473530/Elevai Labs, Inc. announced the pricing of its initial public offering. The Offering consists of 1,500,000 shares of common stock at a public offering price of $4.00 per share, for total gross proceeds of $6,000,000 before deducting underwriting discounts and o
- Aesthetic Trend Spotting With New York City Facial Plastic Surgeon Dr. Jennifer Levinehttps://modernaesthetics.com/news/aesthetic-trend-spotting-with-new-york-city-facial-plastic-surgeon-dr-jennifer-levine/2473529/Regenerative aesthetics and other novel treatments are changing the way that doctors and patients think about and approach facial aging. New York City facial plastic surgeon Jennifer Levine, MD, spoke to AestheticsWire about regenerative aesthetics and other hot trends during
- Study: Lumenato Boosts Skin Barrier Function, Collagen and Ceramideshttps://modernaesthetics.com/news/study-lumenato-boosts-skin-barrier-function-collagen-and-ceramides/2473526/Lycored's Lumenato may improve the skin barrier function and boost collagen and ceramides after 12 weeks of daily supple